Vivanza Biosciences share news, announcements and annual reports
BSE: 530057Pharmaceuticals & BiotechnologySmall Cap
Vivanza Biosciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995
Last close ₹1.54up ₹0.11 (7.69%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹1.43.
30 Oct: open ₹1.50, high ₹1.60, low ₹1.50
52-week range of traded prices to 30 Oct 2026
₹1.30Low, 26 Oct 2026₹2.72High, 17 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6.16 Cr4,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.34
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 24,333
Vivanza Biosciences board meetings
153 filed, newest first. Page 2 of 4.
Sep 2023
1 Sep · Board meeting
Aug 2023
3 Aug · Board meeting
Meeting on 10 Aug 2023: quarterly results
Jun 2023
26 Jun · Board meeting
Meeting on 30 Jun 2023: annual general meeting
Apr 2023
25 Apr · Board meeting
Mar 2023
28 Mar · Board meeting
Meeting on 25 Apr 2023: audited results6 Mar · Board meeting
Meeting on 4 Mar 2023: stock split
Feb 2023
Jan 2023
12 Jan · Board meeting
Meeting on 24 Jan 2023: stock split and quarterly results
Nov 2022
7 Nov · Board meeting
Meeting on 11 Nov 2022: quarterly results
Jul 2022
21 Jul · Board meeting
13 Jul · Board meeting
Meeting on 21 Jul 2022: quarterly results
Jun 2022
17 Jun · Board meeting
Meeting on 21 Jun 2022: preferential issue of shares13 Jun · Board meeting
Meeting on 15 Jun 2022: annual general meeting
May 2022
27 May · Board meeting
18 May · Board meeting
Meeting on 27 May 2022: audited results, quarterly results, preferential issue of shares and annual general meeting
Feb 2022
2 Feb · Board meeting
Meeting on 10 Feb 2022: quarterly results
Oct 2021
22 Oct · Board meeting
Meeting on 28 Oct 2021: quarterly results
Jul 2021
24 Jul · Board meeting
15 Jul · Board meeting
Meeting on 24 Jul 2021: quarterly results
Jun 2021
22 Jun · Board meeting
Meeting on 28 Jun 2021: audited results
Mar 2021
Jan 2021
18 Jan · Board meeting
Meeting on 23 Jan 2021: quarterly results
Oct 2020
9 Oct · Board meeting
Meeting on 17 Oct 2020: quarterly results7 Oct · Board meeting